Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003060205 | SCV003448294 | uncertain significance | Aspartylglucosaminuria | 2022-08-12 | criteria provided, single submitter | clinical testing | This sequence change affects codon 313 of the AGA mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the AGA protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs752718514, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with AGA-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant is not likely to affect RNA splicing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |